Richard Toselli
Chief Executive Officer at INVIVO THERAPEUTICS HOLDINGS CORP.
Net worth: 89 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
C. Merrifield | F | 73 |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | 10 years |
Daniel Marshak | M | 67 |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | 10 years |
Christina Morrison | F | 57 |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | 8 years |
Richard John Roberts | M | 80 |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | 16 years |
Heather M. Hamel | F | - | 7 years | |
Richard C. Christopher | M | 54 | 5 years | |
Robert Rosenthal | M | 67 | 5 years | |
Bruce Robinson | M | 67 | 8 years | |
Parag Gad | M | - |
Spinex, Inc.
Spinex, Inc. Electronic Equipment/InstrumentsElectronic Technology Spinex, Inc. is a clinical-stage bioelectric medtech company based in Northridge, CA. The company develops noninvasive neuromodulation devices for the treatment of neurological conditions, leveraging research from the lab of Dr. V Reggie Edgerton, PhD at UCLA. Spinex offers unique FDA-recognized treatments for neurogenic bladder and cerebral palsy, including the investigational devices SCONE™ and SCIP™. Clinical trial sites can be found on their website. The company was founded by Parag Gad, Evgeniy Kreydin, and Reggie Edgerton, with Parag Gad serving as CEO since incorporation. | 4 years |
Evgeniy Kreydin | M | - |
Spinex, Inc.
Spinex, Inc. Electronic Equipment/InstrumentsElectronic Technology Spinex, Inc. is a clinical-stage bioelectric medtech company based in Northridge, CA. The company develops noninvasive neuromodulation devices for the treatment of neurological conditions, leveraging research from the lab of Dr. V Reggie Edgerton, PhD at UCLA. Spinex offers unique FDA-recognized treatments for neurogenic bladder and cerebral palsy, including the investigational devices SCONE™ and SCIP™. Clinical trial sites can be found on their website. The company was founded by Parag Gad, Evgeniy Kreydin, and Reggie Edgerton, with Parag Gad serving as CEO since incorporation. | - |
Gabe Kalmar | M | - |
Spinex, Inc.
Spinex, Inc. Electronic Equipment/InstrumentsElectronic Technology Spinex, Inc. is a clinical-stage bioelectric medtech company based in Northridge, CA. The company develops noninvasive neuromodulation devices for the treatment of neurological conditions, leveraging research from the lab of Dr. V Reggie Edgerton, PhD at UCLA. Spinex offers unique FDA-recognized treatments for neurogenic bladder and cerebral palsy, including the investigational devices SCONE™ and SCIP™. Clinical trial sites can be found on their website. The company was founded by Parag Gad, Evgeniy Kreydin, and Reggie Edgerton, with Parag Gad serving as CEO since incorporation. | - |
Dean Phizacklea | M | - | 8 years | |
Jennifer Stevenson | F | - | 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christopher McNulty | M | 47 | 5 years | |
Mark D. Perrin | M | 67 | 3 years | |
Omar Ishrak | M | 68 | 9 years | |
Kenneth DiPietro | M | 65 | 6 years | |
Jeffrey Hatfield | M | 66 | 2 years | |
Tamara Joseph | F | 61 | - | |
Michael Leavitt | M | 73 | 10 years | |
Neville Mitchell | M | 65 | 22 years | |
Jeff Modestino | M | - | - | |
Amanda Lampe | F | - | 2 years | |
Melanie Morel-Ferris | F | 44 | 1 years | |
Mark Ziirsen | M | 61 | 5 years | |
William Jones | M | 59 |
Sanofi Corp.
| 2 years |
G. Turenne | M | 50 |
Sanofi Corp.
| 3 years |
Scott Oehrlein | M | 58 |
Sanofi Corp.
| 3 years |
Pete Riojas | M | - |
Sanofi Corp.
| 2 years |
Richard Layer | M | - | - | |
Beth Grous | F | - |
Sanofi Corp.
| 12 years |
Alex Aimetti | M | - | 6 years | |
Jay Blackington | M | - | 3 years | |
Thomas R. Ulich | M | 70 | 3 years | |
Sandy Balkin | M | - |
Sanofi Corp.
| 3 years |
Pamela Stahl | F | 58 | 2 years | |
Sheldon Koenig | M | 58 |
Sanofi Corp.
| - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 29 | 78.38% |
Australia | 6 | 16.22% |
Ireland | 2 | 5.41% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Toselli
- Personal Network